Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.
D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D006562:Herpes Zoster / Q000188:drug therapy* / Q000209:etiology; D014645:Herpesvirus 3, Human / Q000187:drug effects*; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007263:Infusions, Parenteral; D008223:Lymphoma / Q000150:complications; D009369:Neoplasms / Q000150:complications*; D010919:Placebos
D010919:Placebos; D003561:Cytarabine